.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Baxter
Farmers Insurance
Teva
McKinsey
Citi
Argus Health
Chubb
Healthtrust
Harvard Business School

Generated: November 23, 2017

DrugPatentWatch Database Preview

Prochlorperazine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for prochlorperazine and what is the scope of prochlorperazine freedom to operate?

Prochlorperazine
is the generic ingredient in six branded drugs marketed by Able, Glaxosmithkline, Paddock Llc, G And W Labs, Hospira, West-ward Pharms Int, Teva Parenteral, Watson Labs, Athenex Inc, Emcure Pharms Ltd, Wyeth Ayerst, Smith And Nephew, Alpharma Us Pharms, Baxter Hlthcare, Marsam Pharms Llc, Morton Grove, Sandoz, Duramed Pharms Barr, Teva Pharms, Ivax Sub Teva Pharms, Jubilant Cadista, and Mylan, and is included in thirty-nine NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for prochlorperazine. Six suppliers are listed for this compound.

Pharmacology for prochlorperazine

Ingredient-typePhenothiazines
Drug ClassPhenothiazine

Medical Subject Heading (MeSH) Categories for prochlorperazine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Parenteral
PROCHLORPERAZINE EDISYLATE
prochlorperazine edisylate
INJECTABLE;INJECTION040505-001May 30, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
COMPAZINE
prochlorperazine maleate
TABLET;ORAL010571-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
COMPAZINE
prochlorperazine maleate
CAPSULE, EXTENDED RELEASE;ORAL021019-001Oct 6, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
COMPAZINE
prochlorperazine maleate
TABLET;ORAL010571-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
COMPAZINE
prochlorperazine maleate
CAPSULE, EXTENDED RELEASE;ORAL011000-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Morton Grove
PROCHLORPERAZINE EDISYLATE
prochlorperazine edisylate
CONCENTRATE;ORAL088598-001Oct 25, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Morton Grove
PROCHLORPERAZINE EDISYLATE
prochlorperazine edisylate
SYRUP;ORAL088597-001Oct 25, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
COMPAZINE
prochlorperazine edisylate
INJECTABLE;INJECTION010742-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Emcure Pharms Ltd
PROCHLORPERAZINE EDISYLATE
prochlorperazine edisylate
INJECTABLE;INJECTION204147-001Oct 15, 2013APRXNoYes► Subscribe► Subscribe► Subscribe
Glaxosmithkline
COMPAZINE
prochlorperazine
SUPPOSITORY;RECTAL011127-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Julphar
US Department of Justice
Dow
Express Scripts
Moodys
Accenture
UBS
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot